Description AOD-9604 research-grade growth hormone fragment 176-191 (Advanced Obesity Drug) for laboratory study of targeted lipolysis and adipose metabolism
NO completed peer-reviewed trials for individual peptides Research Limitations & Regulatory Status Critical Gaps in Current Evidence Despite extensive preclinical research on individual peptides, the BPC-157 + TB-500 combination faces substantial translational barriers that severely limit its research utility and prevent any clinical application
Most clients benefit from weekly or biweekly treatments, depending on their goals and how they feel
NOTE: The FDA is constantly shifting their position on peptides
Absolutely a game changer
Recalls & Warnings March 06, 2015 Seller of Tea Drinks Warned for Drug Claims On February 26, 2015, the FDA issued a warning letter to the seller of Anamu CancerHerb Tea Box, Anamu CancerHerb Tea Box with Honey and Organic Bottled Tea Drinks because statements made about these products on the websites, www.cancerherbtea.com and www.anamucancerherbtea